Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D00GQM
|
|||
| Former ID |
DNC010262
|
|||
| Drug Name |
(4-(6-morpholino-9H-purin-2-yl)phenyl)methanol
|
|||
| Synonyms |
CHEMBL594669; (4-(6-morpholino-9H-purin-2-yl)phenyl)methanol; SCHEMBL4442909
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
| Structure |
 |
Download2D MOL |
||
| Formula |
C16H17N5O2
|
|||
| Canonical SMILES |
C1COCCN1C2=NC(=NC3=C2NC=N3)C4=CC=C(C=C4)CO
|
|||
| InChI |
1S/C16H17N5O2/c22-9-11-1-3-12(4-2-11)14-19-15-13(17-10-18-15)16(20-14)21-5-7-23-8-6-21/h1-4,10,22H,5-9H2,(H,17,18,19,20)
|
|||
| InChIKey |
GSYUMLARWMDMOF-UHFFFAOYSA-N
|
|||
| PubChem Compound ID | ||||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Novel purine and pyrazolo[3,4-d]pyrimidine inhibitors of PI3 kinase-alpha: Hit to lead studies. Bioorg Med Chem Lett. 2010 Jan 15;20(2):636-9. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.